Monitra Health's upBeat® Revolutionizes Remote Cardiac Monitoring

Monitra Health, through its upBeat® platform, has integrated a full-stack, remote cardiac monitoring system, securing new funding from major investors. The company's innovative approach has led to substantial growth in patient monitoring, revenue, and IP depth. Their technology is redefining remote cardiac monitoring globally.

Monitra Health, the pioneering medtech firm behind the revolutionary upBeat® platform, has announced the successful closure of its latest funding round led by IAN Group. This infusion of capital marks a significant endorsement of Monitra's advanced clinical capabilities and international growth objectives.

Since its last funding cycle in December 2023, Monitra has evolved from a promising startup to a leader in full-stack remote cardiac monitoring. Their upBeat® platform has seen a remarkable uptake, with over 50,000 patients now benefiting from their comprehensive monitoring solution—demonstrating a significant increase from the previous numbers.

Monitra's technology, underpinned by proprietary innovations such as XtremeSpan™, NanoVue™, and DeepFind™, has positioned the company as a rare full-stack provider in the healthcare sector. As the global market for remote cardiac monitoring continues to expand, Monitra Health is poised to cement its status as an industry trailblazer.